Related content

CYP2E1 polymorphisms and gene––environment interactions in the risk of upper aerodigestive tract cancers among Indians

By Soya S S   Vinod T   Reddy K S   Gopalakrishnan S   Adithan C  

Pharmacogenomics, Vol. 9, Iss. 5, 2008-05 ,pp. : 551-560

Future Medicine

Access to resources Recommend Favorite

Determination of urinary 13 C-caffeine metabolites by liquid chromatography-mass spectrometry: the use of metabolic ratios to assess CYP1A2 activity

By Caubet M.-S.   Comte B.   Brazier J.-L.  

Journal of Pharmaceutical and Biomedical Analysis, Vol. 34, Iss. 2, 2004-02 ,pp. : 379-389

Elsevier

Access to resources Recommend Favorite

Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients

By Lee Hon-Kit   Hu Miao   Lui Sandra SH   Ho Chung-Shun   Wong Chun-Kwok   Tomlinson Brian  

Pharmacogenomics, Vol. 14, Iss. 11, 2013-08 ,pp. : 1283-1294

Future Medicine

Access to resources Recommend Favorite

CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine

By Lin Keh-Ming   Tsou Hsiao-Hui   Tsai I-Ju   Hsiao Mei-Chun   Hsiao Chin-Fu   Liu Chia-Yih   Shen Winston W   Tang Hwa-Sheng   Fang Chun-Kai   Wu Chi-Shin   Lu Shao-Chun   Kuo Hsiang-Wei   Liu Shu Chih   Chan Hsiu-Wen   Hsu Ya-Ting   Tian Jia-Ni   Liu Yu-Li  

Pharmacogenomics, Vol. 11, Iss. 11, 2010-11 ,pp. : 1535-1543

Future Medicine

Access to resources Recommend Favorite

Molecular Dynamics Simulations of CYP2E1

By  

Medicinal Chemistry, Vol. 8, Iss. 2, 2012-03 ,pp. : 208-221

Bentham Science Publishers

Access to resources Recommend Favorite